ArticleFrontiers in oncology2020

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma.

Wen Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.